Janet Wygal
Louisville, KYNPI 1891799151
Payments from drug & device makers
$1,751in general payments, 2019–2025
Across 94 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$646
- Astellas Pharma US Inc$239
- Amgen$222
- Hologic Sales And Service, LLC$140
- Therapeuticsmd, Inc.$126
- Pfizer$112
- plus $266 from 15 others
What the payments were for
- Food & beverage$1,55789%
- Education$19411%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
19
20
21
22
23
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 39 | $646 |
| Astellas Pharma US Inc | 5 | $239 |
| Amgen | 9 | $222 |
| Hologic Sales And Service, LLC | 6 | $140 |
| Therapeuticsmd, Inc. | 9 | $126 |
| Pfizer | 8 | $112 |
| Exact Sciences | 3 | $51 |
| Avion Pharmaceuticals | 2 | $25 |
| Urovant Sciences Inc | 1 | $22 |
| Agile Therapeutics, Inc. | 1 | $16 |
| Virtus Pharmaceuticals LLC | 1 | $16 |
| Evofem Biosciences, Inc. | 1 | $15 |
| Duchesnay USA Incorporated | 1 | $15 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Mayne Pharma Commercial LLC | 1 | $14 |
| Merck | 1 | $14 |
| Lupin Inc. | 1 | $14 |
| Alfasigma USA, Inc. | 1 | $13 |
| Bayer | 1 | $13 |
| Zyla Life Sciences, Inc. | 1 | $12 |
| Vertical Pharmaceuticals, LLC | 1 | $11 |
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 33 | $3,285 |
| Estradiol (Twice Weekly)Estradiol | 22 | $2,683 |
| ValacyclovirValacyclovir Hcl | 32 | $1,333 |
| DottiEstradiol | 12 | $972 |
| Alendronate Sodium | 17 | $152 |
| Sertraline Hcl | 13 | $43 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.